(Q40507403)

English

Treatment of Hepatitis E.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

Treatment of Hepatitis E. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Wei Hui

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Linlin Wei

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Zhuo Li

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Xinhui Guo

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 January 2016

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Advances in Experimental Medicine and Biology

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

948

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

211-221

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Liver transplantation: the current situation

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Mystery of hepatitis e virus: recent advances in its diagnosis and management

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Role of immune serum globulins in pregnant women during an epidemic of hepatitis E.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Influence of chronic HBV infection on superimposed acute hepatitis E.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Treatment of chronic hepatitis E in a patient with HIV infection.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Hepatitis E Virus: Time to Change the Textbooks.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Epidemic non-A, non-B hepatitis in patients from Pakistan.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Hepatitis E virus infection in the HIV-positive patient

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Hepatitis E virus-induced severe myositis

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Hepatitis E in liver biopsies from patients with acute hepatitis of clinically unexplained origin

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Treatment of severe acute hepatitis E by ribavirin.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Treatment of chronic hepatitis E with ribavirin: lessons from deep sequencing.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Acute Graft Dysfunction 17 Years After Liver Transplant: A Challenging Clinical and Histologic Manifestation of Hepatitis E.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Hepatitis E virus infection

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Ribavirin for chronic hepatitis E virus infection in transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Therapeutic targets for the treatment of hepatitis E virus infection

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Hepatitis E and Acute-on-Chronic Liver Failure

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Brief communication: case reports of ribavirin treatment for chronic hepatitis E.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Intensive care of the patient with cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Hepatitis E: latest developments in knowledge.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Antiviral therapy in chronic hepatitis E: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Liver transplantation for acute liver failure because of genotype 3 hepatitis E virus infection.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Early goal-directed therapy in the treatment of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Severe acute hepatitis E in an HIV infected patient: Successful treatment with ribavirin.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Hepatitis E Virus Infection Among Chronic Hemodialysis

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Systematic review and meta-analysis of survival following extracorporeal liver support.

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Epidemiology of hepatitis E virus in Iran

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Hepatitis E: Epidemiology and prevention

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Immunopathogenesis of hepatitis E virus infection

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-024-0942-0_12

21 January 2018

Identifiers

10.1007/978-94-024-0942-0_12

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40507403&oldid=1495981683"